Cardiol Therapeutics (CT9.STU) Q1 2026 Earnings

31MarConfirmed
Q1 2026
-0.07
-0.06
-0.05
-0.04

Details

Expected EPS
-0.0719322127854
Actual EPS
-0.044056828199999995
Surprise EPS
0.03
Surprise Percent
+38.75%

Description

Cardiol Therapeutics (CT9.STU) has reported earnings of -0.044056828199999995 per share for Q1 2026.

0 Comments

Share your thoughts